pyrrolidonecarboxylic acid has been researched along with Granulocytic Leukemia, Chronic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bubnova, LN; Glazanova, TV; Kalinina, NM; Ketlinskiĭ, SA; Kulikov, SV; Leonova, EB; Pavlova, IE; Samartsev, MA | 1 |
Karlic, H; Keil, F; Lohninger, A; Louda, N; Paukovits, J; Pfeilstöcker, M; Pittermann, E | 1 |
Bonnet, D; Césaire, R; Guigon, M; Lemoine, F; Najman, A | 1 |
3 other study(ies) available for pyrrolidonecarboxylic acid and Granulocytic Leukemia, Chronic
Article | Year |
---|---|
[A granulopoiesis inhibitor. Synthesis and biological activity].
Topics: Amino Acid Sequence; Cell Division; Granulocytes; Hematopoiesis; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Sequence Data; Oligopeptides; Pyrrolidonecarboxylic Acid; Tumor Cells, Cultured | 1995 |
Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML).
Topics: Animals; Bone Marrow Cells; Cells, Cultured; Chemokine CCL3; Chemokine CCL4; Colony-Forming Units Assay; Cytokines; Growth Inhibitors; Hematopoietic Stem Cells; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Macrophage Inflammatory Proteins; Mice; Oligopeptides; Pyrrolidonecarboxylic Acid | 2001 |
Effects of small peptidic inhibitors of murine stem cells on human normal and malignant cells.
Topics: Animals; Cell Division; Cell Line; Growth Inhibitors; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Monocytes; Neoplasms, Experimental; Oligopeptides; Pyrrolidonecarboxylic Acid | 1991 |